Eli Lilly
| Type | Public |
| HQ | Indianapolis, US |
| Founded | 1876 |
| Size (employees) | 40,655 (est)-3% |
| Website | lilly.com |
Eli Lilly was founded in 1876 and is headquartered in Indianapolis, US
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Eli Lilly
David A. Ricks
Chairman and Chief Executive Officer
Melissa Stapleton Barnes
Senior Vice President, Enterprise Risk Management, and Chief Ethics and Compliance Officer
Enrique A. Conterno
Senior Vice President and President, Lilly Diabetes and Lilly USA
Stephen F. Fry
Senior Vice President, Human Resources and Diversity
Michael J. Harrington
Senior Vice President and General Counsel
Johna L. Norton
Senior Vice President, Global Quality
Report incorrect company information
Eli Lilly Office Locations
Eli Lilly has offices in Puebla, Monterrey, Toluca, Cuernavaca and in 141 other locations
Indianapolis, US (HQ)
Lilly Corporate Center
Melrose Park, AU
112 Wharf Rd
Wien, AT
8-10 Kölblgasse
Toronto, CA
3650 Danforth Ave
Chuo Ward, JP
Sannomiya Plaza Building 7-1-5 Isogami-dori Chuo-ku, Kobe
Windlesham, GB
Erl Wood Manor Sunninghill Road
Report incorrect company information
Eli Lilly Financials and Metrics
Eli Lilly Revenue
Eli Lilly's revenue was reported to be $21.22 b in FY, 2016 which is a 6.3% increase from the previous period.
| USD | |
|---|---|
Market capitalization (15-Oct-2018) | 118.8b |
Closing stock price (15-Oct-2018) | 110.6 |
Eli Lilly's current market capitalization is $118.8 b.
Eli Lilly Operating Metrics
| FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|---|
Phase III Trials Products | 8 | 7 | 17 | 19 |
Projects in R&D Pipeline | 57 | 57 | 65 | 66 |
Eli Lilly Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| AurKa Pharma | May 15, 2018 | $575 m |
| ARMO BioSciences Inc | May 11, 2018 | $1.60 b |
| CoLucid Pharmaceuticals | January 18, 2017 | $960 m |
| Novartis Animal Health | April 22, 2014 | $5.40 b |
| Avid Radiopharmaceuticals | November 08, 2010 | $800 m |
| Alnara Pharmaceuticals | July 02, 2010 | $280 m |
| Imclone Systems | October 06, 2008 | $6.50 b |
Report incorrect company information
Eli Lilly Online and Social Media Presence
182.32k Facebook likes
Eli Lilly has 182.32k Facebook Likes. The number of likes has increased 2% month over month and increased 5.5% quarter over quarter
Report incorrect company information
Eli Lilly News and Updates
October 16, 2018
Diabetes Management Market 2018 Global Analysis By Key Players – Abbott, Bayer, Bristol-Myers Squibb, Eli Lilly, Sanofi, Dexcom
WiseGuyReports.Com Publish a New Market Research Report On –“ Diabetes Management Market 2018 Global Analysis By Key Players – Abbott, Bayer, Bristol-Myers Squibb, Eli Lilly, Sanofi, Dexcom”. Posted via Industry Today. Follow us on Twitter @IndustryToday
October 16, 2018
Biologics 2018 Global Market Key Players – Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion – Analysis and Forecast to 2023
WiseGuyRerports.com Presents “Global Biologics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
October 15, 2018
Global Pain Management Drugs 2018-2025 Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Latest Report Available at Analytical Research Cognizance ,Pain Management Drugs Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth. Posted via Industry Today. Follow us on Twitter @Indust…
October 11, 2018
Eli Lilly enters autoimmune segment in India with launch of Olumiant
Drug firm Eli Lilly and Company Thursday said it has entered the autoimmune segment in India with launch of Olumiant, a new once-daily oral therapy for treatment of rheumatoid arthritis.
Olumiant is approved in more than 50 countries across the world, it said.
"Lilly India is excited to announce the…
October 11, 2018
Eli Lilly plans expansion, looks to grow presence in Indian market
Eli plans to bring some of its molecules from the global pipeline to India, especially in the oncology and diabetes space
October 04, 2018
Eli Lilly stock gets bump after results for its mid-stage diabetes drug trial shows positive results (LLY)
On Thursday, pharma giant Eli Lilly and Co. announced positive results in a mid-stage trial for its experimental new diabetes drug. The company's stock rose 3% on the news.
The drug significantly reduced blood sugar levels and promoted weight loss in patients with type 2 diabetes.
The late-stage…
Report incorrect company information
Eli Lilly Company Life and Culture
Report incorrect company information